Fiera Capital Corp Sells 33,571 Shares of CME Group Inc. (NASDAQ:CME)

Fiera Capital Corp lowered its position in CME Group Inc. (NASDAQ:CME - Free Report) by 1.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,304,319 shares of the financial services provider's stock after selling 33,571 shares during the quarter. CME Group comprises approximately 2.2% of Fiera Capital Corp's investment portfolio, making the stock its 11th biggest holding. Fiera Capital Corp owned 0.92% of CME Group worth $729,098,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Capital International Investors grew its holdings in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider's stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. PineStone Asset Management Inc. increased its stake in CME Group by 137.6% during the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider's stock valued at $444,443,000 after acquiring an additional 1,309,097 shares during the period. M&G Plc bought a new stake in shares of CME Group in the 1st quarter worth approximately $156,631,000. Assenagon Asset Management S.A. grew its holdings in shares of CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider's stock worth $126,872,000 after purchasing an additional 550,133 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider's stock valued at $1,038,676,000 after purchasing an additional 537,758 shares during the period. 87.75% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business's stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company's stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Sunil Cutinho sold 4,500 shares of the company's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now directly owns 27,053 shares in the company, valued at approximately $6,131,291.92. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 in the last 90 days. Company insiders own 0.30% of the company's stock.

CME Group Stock Performance

Shares of CME stock traded up $3.62 during trading hours on Friday, hitting $225.66. The stock had a trading volume of 1,797,428 shares, compared to its average volume of 1,918,665. The firm has a market capitalization of $81.26 billion, a PE ratio of 23.73, a PEG ratio of 5.61 and a beta of 0.55. The stock's 50 day moving average is $221.72 and its 200 day moving average is $209.91. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts' consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm posted $2.25 earnings per share. The company's quarterly revenue was up 18.4% compared to the same quarter last year. As a group, research analysts forecast that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. CME Group's dividend payout ratio (DPR) is presently 48.37%.

Analyst Ratings Changes

A number of research firms have recently issued reports on CME. Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research note on Thursday, October 24th. Bank of America upped their target price on shares of CME Group from $177.00 to $180.00 and gave the stock an "underperform" rating in a research report on Thursday, October 3rd. Redburn Atlantic lowered shares of CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Keefe, Bruyette & Woods raised their price target on CME Group from $212.00 to $213.00 and gave the company a "market perform" rating in a report on Thursday, July 25th. Finally, Piper Sandler lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an "overweight" rating in a research note on Monday, October 28th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, CME Group presently has a consensus rating of "Hold" and a consensus target price of $222.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.